Financial Advocates Investment Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,865
| Closed | -$800K | – | 121 |
|
|
2025
Q2 | $800K | Sell |
2,865
-5,431
| -65% | -$1.54M | 0.07% | 266 |
|
|
2025
Q1 | $2.58M | Sell |
8,296
-1,816
| -18% | -$536K | 0.18% | 133 |
|
|
2024
Q4 | $2.64M | Sell |
10,112
-5,273
| -34% | -$1.56M | 0.15% | 149 |
|
|
2024
Q3 | $4.96M | Buy |
15,385
+545
| +4% | +$178K | 0.28% | 85 |
|
|
2024
Q2 | $4.64M | Buy |
14,840
+6,124
| +70% | +$1.8M | 0.29% | 79 |
|
|
2024
Q1 | $2.48M | Buy |
8,716
+41
| +0.5% | +$12K | 0.14% | 158 |
|
|
2023
Q4 | $2.5M | Buy |
8,675
+511
| +6% | +$139K | 0.16% | 139 |
|
|
2023
Q3 | $2.19M | Buy |
8,164
+278
| +4% | +$69.4K | 0.16% | 146 |
|
|
2023
Q2 | $1.75M | Buy |
7,886
+1,268
| +19% | +$294K | 0.12% | 183 |
|
|
2023
Q1 | $1.6M | Buy |
6,618
+1,288
| +24% | +$316K | 0.12% | 206 |
|
|
2022
Q4 | $1.4M | Buy |
5,330
+2,899
| +119% | +$777K | 0.1% | 223 |
|
|
2022
Q3 | $542K | Sell |
2,431
-2,255
| -48% | -$547K | 0.04% | 397 |
|
|
2022
Q2 | $1.14M | Buy |
4,686
+1,905
| +69% | +$467K | 0.09% | 243 |
|
|
2022
Q1 | $673K | Sell |
2,781
-9
| -0.3% | -$2.07K | 0.04% | 382 |
|
|
2021
Q4 | $628K | Sell |
2,790
-322
| -10% | -$68K | 0.04% | 433 |
|
|
2021
Q3 | $662K | Buy |
3,112
+232
| +8% | +$53.4K | 0.04% | 408 |
|
|
2021
Q2 | $702K | Buy |
2,880
+173
| +6% | +$42.6K | 0.05% | 394 |
|
|
2021
Q1 | $674K | Sell |
2,707
-1,571
| -37% | -$375K | 0.05% | 409 |
|
|
2020
Q4 | $983K | Buy |
4,278
+219
| +5% | +$50.5K | 0.07% | 309 |
|
|
2020
Q3 | $1.03M | Sell |
4,059
-20
| -0.5% | -$4.96K | 0.09% | 241 |
|
|
2020
Q2 | $962K | Buy |
4,079
+64
| +2% | +$14.6K | 0.09% | 257 |
|
|
2020
Q1 | $814K | Sell |
4,015
-141
| -3% | -$30.8K | 0.12% | 206 |
|
|
2019
Q4 | $1M | Sell |
4,156
-257
| -6% | -$56.7K | 0.11% | 211 |
|
|
2019
Q3 | $846K | Buy |
4,413
+49
| +1% | +$9.4K | 0.1% | 212 |
|
|
2019
Q2 | $804K | Sell |
4,364
-433
| -9% | -$77.5K | 0.09% | 212 |
|
|
2019
Q1 | $911K | Buy |
4,797
+286
| +6% | +$54.6K | 0.11% | 194 |
|
|
2018
Q4 | $878K | Sell |
4,511
-2,171
| -32% | -$424K | 0.12% | 185 |
|
|
2018
Q3 | $1.39M | Buy |
6,682
+356
| +6% | +$70.2K | 0.15% | 146 |
|
|
2018
Q2 | $1.17M | Buy |
6,326
+623
| +11% | +$110K | 0.14% | 153 |
|
|
2018
Q1 | $972K | Sell |
5,703
-255
| -4% | -$46.8K | 0.13% | 167 |
|
|
2017
Q4 | $1.04M | Buy |
+5,958
| New | +$1.05M | 0.14% | 155 |
|
Other funds holding AMGN
Financial Advocates Investment Management's AMGN Position: Q3 2025 in Review
Financial Advocates Investment Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 2,865 shares — an estimated $800K sold.
Financial Advocates Investment Management first reported a position in AMGN in Q4 2017 and held it in 31 quarters. The position peaked at $4.96M in Q3 2024. 2,820 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.
- Financial Advocates Investment Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
- Financial Advocates Investment Management sold 2,865 Amgen shares in Q3 2025, an estimated $800K.
- Financial Advocates Investment Management first reported a position in Amgen in Q4 2017 and held it in 31 quarters.
- Financial Advocates Investment Management's Amgen position peaked at $4.96M in Q3 2024.
- 2,820 funds tracked by Wall St. Rank held Amgen as of Q3 2025.
Based on Financial Advocates Investment Management's 13F filing for Q3 2025, filed 6 Nov 2025.